A new study reveals that obesity-related changes in body fat can disrupt brain signals and immune function, potentially worsening Alzheimer's disease.
'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'
Over the past year, the sale of injectable GLP-1 agonists (used to treat type 2 diabetes and obesity) such as Mounjaro, Wegovy and Ozempic have surged a whopping 218 per cent.
'Don't chase unrealistic expectations or compare yourself to social media transformations.' 'Focus on your health first, not just the number on the scale before the wedding.'
Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the fast-growing diabetes and obesity market currently dominated by the likes of Novo Nordisk and Eli Lilly.
The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.
'...would obesity still be a global epidemic?'
PCOS is being renamed PMOS. Dr Anagha Menon breaks down why the one alphabet change matters and how it affects the diagnosis of this condition for so many women.
Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a "long-term" opportunity in India's fast-evolving obesity and cardiometabolic therapy market, even as price competition in the glucagon-like peptide-1 (GLP-1) segment intensified.
Rising mercury levels in Madhya Pradesh are causing sleepless nights for residents as minimum temperatures remain high. Doctors report an increase in sleep-related issues, allergies, and fatigue due to the heat.
Rising mercury levels in Madhya Pradesh are causing discomfort for residents as night temperatures fail to provide relief, disrupting sleep patterns and daily routines.
The fast-growing GLP-1 market, propelled by lower-cost generics following patent expiry, is widening availability beyond patients with obesity and diabetes -- but also driving unsupervised, appearance-led demand, according to doctors.
'The unregulated marketing has to stop. People are getting recommendations for this from gym trainers, from marriage counsellors -- that is simply unacceptable.' ''There are many ways to lose weight -- eat less, fast, exercise, eat healthy. That is how you lose weight.'
'Refined carbohydrates are the quiet troublemaker in our diet.' 'We eat plenty of calories, but not enough nutrition.'
Biocon is actively seeking in-licensing opportunities to expand its biosimilars portfolio, focusing on products that complement existing therapy areas, as the company shifts to a 'consolidate' phase with a strong emphasis on improving capacity utilisation, expanding margins, and driving return on capital employed.
Pharmaceutical major Cipla reported a 3 per cent year-on-year decline in March quarter revenue to Rs 6,541 crore, with net profit falling 55 per cent to Rs 554.6 crore, missing consensus estimates. Despite strong growth in India and Africa, a significant decline in North American sales impacted overall performance, with the company now focusing on new product launches and regulatory filings to drive future gains.
Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections, used for treating diabetes and obesity. Two people have been arrested, and a nationwide alert has been issued to trace counterfeit batches.
An independent think tank on policing has called for a multi-agency investigation into the recent unearthing of a spurious Mounjaro (tirzepatide) injection manufacturing racket in Gurugram, offering free-of-cost forensic expertise.
Young adults show alarming NCD trends, with high rates of obesity, prediabetes, and abnormal cholesterol levels.
'In all these years of rupee depreciation, of rising oil prices, of inflation caused by import dependence, not one leader had the courage to look the people in the eye and say: Please do this for your country.'
Inspections conducted across 49 entities including pharmacies, wholesalers, and clinics to detect violations and misleading marketing practices.
A Swedish study reveals that individuals born with low birth weight face a significantly elevated risk of stroke in early adulthood, regardless of their BMI or gestational age.
'Infertility and reproductive health challenges, much like other chronic conditions, are rising globally.'
The number of Indian obese adults increased from 5.76 million in 1991 to 46.78 million in 2021; it is poised to reach 173.73 million by 2050.
The Union health ministry is urging all ministries and departments to display 'oil and sugar boards' in common areas to raise awareness about hidden fats and sugars in everyday foods and promote healthier lifestyles.
While the introduction of branded generics is likely to accelerate volumes for GLP-1 agonists, value growth may moderate because of price erosion.
At the heart of this debate is Section 3(d) of the Patents Act, a safeguard designed to prevent drugmakers from extending monopoly protection through trivial modifications to existing medicines.
'Weight loss drugs can be life changing but are not without risks,' says Dr Vishnu Radhakrishnan as he explains the truth behind Ozempic and Mounjaro.
The Central Board of Secondary Education (CBSE) has directed schools to set up dedicated 'Sugar Boards' to raise awareness about sugar consumption and combat childhood obesity. Experts hail the initiative as a significant step towards promoting healthier dietary habits among students and families. The boards will display information on the sugar content in common snacks, drinks, and meals, helping children make informed choices. This move comes as data reveals alarmingly high sugar intake among Indian children, exceeding the World Health Organization's recommended limits.
Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.
Prime Minister Narendra Modi, in his monthly 'Mann Ki Baat' radio broadcast, urged people to reduce their oil intake by 10% as a step towards fighting obesity. He highlighted the rising obesity rates in India and globally, emphasizing the need for healthier lifestyles. Modi also shared messages from Olympic medalist Neeraj Chopra and boxer Nikhat Zareen, who urged people to adopt healthy habits and avoid fried food. Cardiac surgeon Dr. Devi Shetty highlighted the medical seriousness of obesity and linked it to excessive carbohydrate intake and oil consumption. Modi concluded by challenging 10 people to reduce their oil intake and pass the challenge on to 10 others.
'As more patients are prescribed these drugs, intolerance due to gastrointestinal and other side effects will become more visible, leading to higher discontinuation rates.'
Olympic medallists Manu Bhaker and Mirabai Chanu have joined Prime Minister Narendra Modi's initiative to combat obesity, emphasizing the importance of healthy lifestyle choices.
A strong third-quarter (October-December/Q3) performance for 2025-26 (FY26) has helped the stock of India's largest listed pharmaceutical (pharma) company, Sun Pharmaceutical Industries, gain about 7 per cent since the start of February.
'Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.'
Following too sedentary a routine is closely linked to weight gain, disrupted blood sugar levels, heart-related conditions, dangerous blood clots and a cluster of metabolic disorders that quietly damage long-term health, continues Harvard Medical School.
Dr Rahul Gupta, director-cardiologist at Gleneagles Hospital, Mumbai, shares simple habits that will help you prioritise your heart's health.
Experts warn that air pollution in India is a major public health crisis, leading to a surge in undiagnosed airway diseases and cardiovascular issues. They urge for urgent action, early detection, and treatment.
The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage.
University College London has recorded a 19 per cent and 26 per cent rise in undergraduate and postgraduate students from India for the 2026 term, indicating a preference for the UK over the US at a time when Indian students are facing visa uncertainties in US-based institutions.
